Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000117055 | SCV000222838 | benign | not specified | 2012-06-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000117055 | SCV000250337 | benign | not specified | 2015-06-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000757303 | SCV000556023 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620290 | SCV000738366 | benign | Cardiovascular phenotype | 2015-06-23 | criteria provided, single submitter | clinical testing | Lines of evidence used in support of classification: General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Ambry Genetics | RCV000717376 | SCV000848226 | benign | History of neurodevelopmental disorder | 2015-06-23 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
ARUP Laboratories, |
RCV001811964 | SCV000885471 | benign | not provided | 2021-04-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498512 | SCV002810237 | likely benign | Cardiac valvular dysplasia, X-linked; FG syndrome 2; Heterotopia, periventricular, X-linked dominant; Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked; Melnick-Needles syndrome; Oto-palato-digital syndrome, type I; Oto-palato-digital syndrome, type II; Terminal osseous dysplasia-pigmentary defects syndrome; Frontometaphyseal dysplasia 1 | 2021-08-23 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000117055 | SCV004029219 | benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000117055 | SCV000151190 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Genome Diagnostics Laboratory, |
RCV000117055 | SCV001809728 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000117055 | SCV001974168 | benign | not specified | no assertion criteria provided | clinical testing |